Glypican-3 knockdown inhibits the cell growth, stemness, and glycolysis development of hepatocellular carcinoma cells under hypoxic microenvironment through lactylation.
Gebing YaoZihua Yang
Published in: Archives of physiology and biochemistry (2023)
GPC3-mediated lactylation modification may be a new direction in HCC treatment in the future.